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"Reactive hemolysis" describes a form of red cell lysis which can be differentiated 
from classical  complement lysis by the fact that it occurs in the absence of antibody 
on the red cells and in the presence of ethylenediaminetetraacetic acid (EDTA) (1). 
The salient feature is that the hemolysis occurs as a result of the fluid phase inter- 
action of  two serum factors in the presence of  the cells.  These factors have provi- 
sionally been called activated reactor, and indicator (hereafter frequently referred to 
for  convenience, as  activated R  and I,  respectively). I  is a  normal serum protein 
whereas activated R can be obtained only from some sera (usually acute phase sera), 
and has to be generated by incubation at 37°C with such agents as sensitized bacteria 
or zymosan, in circumstances which allow complement activation. The evidence that 
activated R  is a stable complex of the complement components C5 and C6 is given 
in a separate publication (2). 
During the generation of activated R  in those sera which show it, I  activity 
is lost as a  consequence of the mutual inactivation of the two factors,  the re- 
sulting serum showing the activity of the factor present in excess. Evidence is 
presented here that I  is identical with the seventh component of complement 
(C7).  Its  physicochemical  and  antigenic  characteristics  and  a  convenient 
method of quantitation are described. 
Materials and Methods 
Activated Reactor was prepared as described in (2). 
Antisera.--Anfisera specific to human IgG, IgA, IgM, and IgD were obtained as previ- 
ously described (1). Polyvalent anti-human serum was obtained from Burroughs & Wellcome 
Co., Beckenham, England. 
Antisera to Complement Components.-- 
* Part of the work was carried out while Dr. Thompson was in receipt of a grant from the 
John Squire Memorial Fund. Grants to Dr. Lachmann from the Nuffield Foundation and 
the Medical Research Council are also gratefully acknowledged. 
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C3:  antiserum to C3 was made by immunizing rabbits with immune precipitates coated 
with human complement. A further antiserum was made by injecting rabbits with well washed 
precipitin lines from immunodiffusion plates  between the antiserum and  human  C3.  This 
second antiserum was  monospecific  when  tested  against  a  variety  of serum  fractions by 
Ouchterlony analysis. 
C4:  An antiserum to  C4 was made by immunization with ~m-anti- ritE precipitin lines 
cut from immunoelectrophoretic plates. The  antiserum gave one unidentified precipitation 
line as well as the C4 line on Ouchterlony analysis. 
C5:  An antiserum to  C5  was similarly made by injection with precipitin lines between 
normal euglobulin and an anti-C5 antiserum kindly supplied by Dr. U. Nilsson. It produced 
a minor precipitin line against C3, as well as a C5 line. 
C6: Antiserum to C6 was made by immunizing C6-deficient rabbits with partially  puri- 
fied  rabbit  C6  (3).  The  antiserum precipitated well  with human  serum  and was  entirely 
monospecific. 
Cg: An antiserum to C8 was generously given by Dr. H. J. Mfiller-Eberhard. It gave pre- 
cipitin lines with IgG and two unidentified contaminants as well as to C8. 
Reactive Hemolysb was demonstrated in 1% agarose plates made up in 0.01 M EDTA in 
buffered saline and containing 1% sheep cells.  (E/EDTA/agarose plates). 
Gelfiltration on Sephadex G-200 (Pharmacia Fine Chemicals,  Uppsala, Sweden) was carried 
out in 2.4 X  60 cm columns using a 0.5 N NaC1 buffered with .01  M phosphate pH 7.2, con- 
taining 0.01 ~  azide. 
Ultracentrifugation  in  a  sucrose density gradient was carried out in  a  Spinco  Model E 
ultracentrifuge according to the method of Stanworth (5), using hemoglobin IgG and IgM 
globulin as internal markers. 
Diffusion coedficient in agar was measured by the method of Atlison  and Humphrey (6) 
using a rabbit anti-I antiserum. (See Results.) 
Chromatography  on  diethylaminoethyl  (DEAE)-cellulose  (Whatman  DE32)  was  carried 
out in 100  X  2.5 cm columns, in buffers containing 25% or 40% glycerol.  In some prepara- 
tions 0.01 ~  phosphate buffer, pH 7, was used as starting buffer and gradient elution was 
performed with the same buffer containing 0.3 ~ NaC1. In others, 0.01 M phosphate, pH  7.9, 
was used as starting buffer and gradient elution was performed with 0.25 M NaH2PO4.  The 
elution patterns obtained were essentially similar. 
Chromatography on hydroxyapatite was carried out in 40 X  2.5 cm columns using the buffer 
systems described by Miiller-Eberhard (7). 
lgG fractious  of various antisera were prepared by column  chromatography on  DEAE- 
cellulose  (Whatman DE32)  of the whole serum  equilibrated with 0.015 M phosphate buffer, 
pH 7.0. The exclusion  peak collected  and precipitated by 50% saturation  with ammonium 
sulfate. 
Complement Compounds.--Partially purified C1  was prepared by  the method of Nelson 
and coworkers (8). Partially purified C2 was prepared by chromatography on carboxymethyl 
(CM)-cellulose  of the supernatant left after precipitation of serum by 20% Na2SO4. Partially 
purified C4 was prepared by chromatography on DEAE-cellulose of the pseudoglobulin pre- 
pared from the 20%  Na2SO4 precipitate of serum.  Partially purified C3  was prepared by 
chromatography on DEAE-cellulose of the euglobulin  from the 20% Na2SO4 precipitate. The 
conditions for the chromatography were substantially similar to those described in (7). 
Functionally purified C8 was obtained as a gift from Dr. It. J. Mtiller-Eberhard. 
Intermediate Complexes.-- 
EAC 142 GP was prepared by incubating EA  t for 5 min at 37°C with zymosan-absorbed 
1 Complement nomenclature is used in accordance with the recommendations of the World 
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guinea pig serum (4). These cells were negative in the immune adherence reaction, but were 
rapidly lysed by EDTA-C. 
EAC 1423 (Hu) was prepared by incubating EA for 3 min at 32°C with selected, zymosan- 
absorbed, human serum (14). The intermediate was positive in immune adherence and aggre- 
gated by conglurinin and anti-human C3 sera. Its capacity to be lysed by EDTA-C was very 
unstable and for lyric tests the cells were used immediately without washing. 
EAC 1 ~  7 was prepared initially by incubating EAC142GP with an appropriate dilution 
of a human C3 fraction from DEAE-chromatography of euglobulin for 30 rain at 37°C. More 
recently EC567  have been made with activated reactor and functionally purified indicator. 
EAC  1 ~  8.  This intermediate was  characterized  by its  ability to  be lysed  by 0.01 
phenanthroline (9). EAC 1 ~  8 were made initially  by treating EAC 1 with a DEAE fraction 
of human pseudoglobulin containing C4-C8.  More recently EC5678  cells have been made 
using functionally purified activated R and DEAE-fractionated indicator preparations (2). 
Tests for the Presence of Complement  Component  Activity.-- __ 
C1  was detected  by its ability to convert EAC42  to EAC42;  the latter being lysed by 
EDTA-C. 
C1 inhibitor  was tested by the method of Levy and Lepow  (10). 
C2 was detected by the ability to convert EAC 14 (human) to EAC142 which could then 
by lysed by EDTA complement. 
(24 was tested by the ability to lyse EA in the presence of ammonia-treated guinea pig 
serum. 
C3 was detected  by the ability to lyse EAC  142  (guinea pig)  in the presence of dilute 
ammonia-treated guinea pig serum (11). 
C6 was detected by the ability to lyse EA in the presence of C6-deficient  rabbit serum. 
C9 was detected by the ability to Iyse EAC 1 ~  8 intermediates. 
Conglutinogen-activating factor  (KAF) was measured by its ability to make EAC  1 --~ 3 
reactive with conglutinin (17). 
RESULTS 
The  Purification  of  Indicator  Factor.--Euglobnlin  was  prepared  from  the 
20%  sodium  sulfate  precipitate  of  500  ml  fresh  human  serum.  The  elution 
diagram of this  euglobulin preparation from DEAE-cellulose is shown in Fig. 
1.  It  is  seen  that  indicator  was  eluted  maximally at  0.6  millimhos/cm after 
KAF  and  before  the  major  protein  peak  containing C3  (and  C6).  However, 
some trailing of indicator was consistently found. 
Indicator-containing  fractions  were  pooled  and  concentrated  by  ultra- 
filtration.  Antigenically,  these  fractions  contained  IgG  and  C8  as  well  as 
indicator. 
The indicator fraction from the DEAE  column was further fractionated  on 
hydroxyapatite.  The  I  activity  was  eluted  at  a  conductivity  of  11-12 
millimhos/cm.  Indicator-containing fractions  were  pooled  and  concentrated. 
Antigenically,  the  pool  contained  only  indicator  and  some  IgG,  and  was 
functionally pure. 
Physicochemical  Characterization  of  Indicator  Factor.--Indicator  factor  has 
previously been reported to migrate in agar electrophoresis as a/31-fl2 globulin. 
It was eluted from Sephadex G-200 in the second (7S) protein peak, and quanti- 
tation  of indicator  activity  (by the  method  discussed  below)  showed  that  it 632  REACTIVE  LYSIS.  I 
occurred maximally on the descending slope of the second protein peak. In the 
ultracentrifuge, indicator activity sedimented more slowly than IgG (Fig.  2) 
with a calculated S value of 5.7  (mean of three values). 
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Fla.  I.  Fractionation of euglobulin on DEAE-cellulose. 500 mg of human euglobulin pre 
pared from a  20% Na2SO4 precipitate of one unit fresh human serum was applied to a  2.5 X 
100 cm DEAE column equilibrated with 0.01 ~t phosphate buffer, pH 7.9 with 409;)  glycerol. 
Gradient  elution was performed with 0.25 ~  NaH2PO4 with 40%  glycerol.  The column was 
pumped upwards at 30 ml/hr and 12.5 ml fractions were collected. 
The diffusion coefficient, as determined by the method of Allison and Hum- 
phrey (6) was 4.0 X  l0  -r cm  2 per sac. Assuming a value of 0.73 for ,7, the mo- 
lecular weight was calculated to be about 140,000. 
Quantitative  Estimation of Indicator Activity.--Indicator  could be measured 
quantitatively  by  titration,  using  E  and  purified  preparations  of  activated 
reactor (2). R.  A.  THOMPSON  AND  P.  J.  LACHMANN  633 
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However,  this  method  was  time  consuming,  and  much  subject  to  inter- 
ference by inhibitors. It has been found more convenient  to incorporate acti- 
vated reactor into E/EDTA/agarose plates and to measure indicator by single 
radial diffusion,  simulating the  technique  of  antigen  quantitation  elaborated 
by Mancini and coworkers (12). 
Holes  made  in  the  agarose  were  filled with  sera,  or  indicator  containing 
preparations, and left for 24 hr at room temperature.  Circular zones of partial 
lysis developed around the holes in which whole sera or indicator preparations 
were placed (Fig. 3).  The  diameters of the zones  were well defined and easily 
read to the nearest 0.1  mm,  using an eyeglass which incorporated a  measuring 
FIG. 3.  The single radial diffusion method of quantitation of I. An activated reactor euglo- 
bulin was incorporated in to a red cell agarose plate with EDTA. Holes of 2 mm diameter 
were made in the agar and filled with serial doubling dilutions of a standard human serum 
(upper  row, left to right, 1:2 to  1:64)  or dilutions of test sera (lower row, all sera diluted 
1:10), or indicator containing preparations. After being left at room temperature for 24 hr, 
the diameter of the zones of partial lysis around  the holes were measured  using an eyepiece 
incorporating a measuring  scale. 
scale.  No  lysis  occurred  in  EDTA  red  cell  agarose  plates  incorporating  an 
activated R  preparation which had been  destroyed by heating  at 56°C  or by 
treatment with ammonia. 
The  diameters  of  the  zones  on  any  one  plate  were  linearly related  to  the 
logarithm of the concentrations of the indicator preparations (Fig. 4).  Regard- 
less of its eventual size, the zone of lysis was always partial, being maximal at 
the  outer  margin  of  the  circle.  Purified  indicator  preparations  showed  more 
complete lysis than whole serum. 
This method  proved satisfactory for  the quantitation  of indicator in whole 
human  sera  or  in  fractions.  By  repeated  estimations  on  3  separate  days  in 
which each of six sera were analyzed 15  times,  the standard error of the method 
was  calculated  as  =t=9.1%.  These  estimations  were  performed  with  different 
activated reactor  euglobulin  preparations  incorporated in  the  plates  on  each 
occasion. R.  A.  THOMPSON AND  P.  J.  LACHMANN  635 
Antigenic Characterization oflndicator.--By injecting a rabbit with a partially 
purified  indicator,  an  antiserum  was  obtained  which  gave  a  number  of lines 
with the injected preparation,  the main arcs being fllA and IgG. By selectively 
cutting out a small precipitation line in the agar in the electrophoretic position 
of indicator and injecting it in to other rabbits, after the technique described by 
Goudie  et  al.  (13),  an  antiserum  was  obtained  which,  although  not  specific, 
after  absorption with  a  reconstructed freeze-dried  Cohn III 2,  3  preparation, 
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FIG. 4. The relationship between the logarithm of the concentration  of a standard  serum 
(ordinate), to the diameter of the zone of reactive hemolysis (abscissa) produced in a red cell 
agarose EDTA plate incorporating an activated  R euglobulin after 24 hr incubation at room 
temperature.  Each point is the mean 4- one sD of six estimations. 
showed  only  a  single  line  in  the  position  of  the  indicator  factor  when  run 
against  the  partially  purified  indicator.  With  whole  serum,  the  absorbed 
antiserum  showed one major line  which  gave a  reaction  of identity  with  the 
line given against the indicator preparation.  This major line was antigenically 
distinct from IgA, IgG, IgM, and IgD, transferrin, fllc-fll~ and/32 glycoprotein.  2 
The  commercial  polyvalent  anti-human  serum  protein  antiserum  was  also 
shown to contain antibodies to indicator which gave a reaction of identity with 
the line produced by the absorbed rabbit antiserum against the partially puri- 
fied I  preparation. 
This  precipitating  antibody  was  shown  to  be  directed  against  indicator 
2 Supplied as a gift from Mr. D. Evans of Behringwerke AG, Marburg-Lahn,  West Ger- 
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FIG. 5.  The relationship of the antigenic I  to  the hemolytic activity after electrophoresis 
in  agar  of a  DEAE-I  preparation.  Anode is to  the right.  After electrophoresis,  the strip  of 
agar was cut out parallel to the direction of separation, as shown, and replaced with a similar 
sized strip of agarose incorporating sheep red cells, 0.01 ~  EDTA, and an activated R  euglo- 
bulin.  The  upper  trough  (A)  was  filled  with  polyvalent  anti-human serum  and  the lower 
trough (B) with anti-I. The preparation was photographed after incubation for 18 hr at room 
temperature. 
FIG. 6.  A  section of a  red cell agarose plate.  The four wells contained  indicator  (I),  acti- 
vated reactor  (R),  the IgG fraction of rabbit  anti-I antiserum (AS),  and saline (S).  After 24 
hr at  room  temperature,  the plate was photographed  to  show the hemolysis between I  and 
R. It was washed in 0.15 M NaC1, and then in distilled water to hemolyze the red cells. When 
the hemoglobin had been washed out of the plate,  it was photographed to show the precipi- 
tation between I  and  the antiserum, and the two photographs superimposed to illustrate the 
action of the anti-I in inhibiting reactive hemolysis. R. A. THOMPSON  AND  P. J. LACIIMANN  637 
factor in a number of ways. Firstly,  the position of the precipitin lines on im- 
munoelectrophoresis can be shown to correspond to the position of hemolytic 
indicator activity (Fig. 5). Secondly, IgG prepared from the absorbed antiserum 
removed hemolytic indicator activity from serum or from indicator-rich  frac- 
tions,  as shown in Fig.  6,  where  the line  of reactive hemolysis stops short  at 
the  precipitation  line  between  the  indicator  and  the  anti-indicator  IgG.  IgG 
similarly  obtained  from  normal  rabbit  serum  or  from  rabbit  anti-human 
immunoglobulin  antisera,  did  not  interrupt  the  line  of  reactive  hemolysis. 
The effect of the anti-indicator IgG was specific for human indicator and had 
no effect on the reaction between activated reactor and the indicator in rabbit 
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FIG. 7. The comparison of the hemolytic and immunochemical radial diffusion methods of 
estimating I in 12 different sera. The results are expressed as the percentage of I in the par- 
tially purified preparation.  In the hemolytic method, dilutions of sera were placed in wells 
in an E/EDTA/agarose plate  incorporating  activated  R  euglobulin, while in  the immuno- 
chemical method, plain agarose plates incorporating anti-I antiserum were used. 
serum  or guinea pig serum.  Further,  by incorporating  the  antiserum  into an 
agar plate,  it was possible to determine  the concentration of immunochemical 
indicator by the single radial diffusion technique,  and there was good correla- 
tion between  the values  obtained by this  method in  12  sera,  with  the values 
for hemolytic activity obtained in the same sera by the "hemolytic radial dif- 
fusion" method already described (Fig. 7). 
The Interaction of Activated R  and I  in Plain Agarose plates.--During  the 
analysis of the antigenic characterization of indicator, in plain agar or agarose, 
it was observed that between activated R  and indicator preparations,  whether 
highly purified  or  in  serum,  a  line  invariably  developed.  This  line  could  be 
demonstrated by a  protein stain,  but was never visible as a  precipitate  in the 
unstained preparation (Fig. 8). It was not found if the activated R preparations 638  REACTIVE  LYSIS.  I 
had  been heated  for  10 min at  56°C  to destroy their  hemolytic activity.  The 
line  could also be  seen  by appropriate  preparation  of a  red  cell  agarose plate 
and  when  compared  with  a  photograph  of  the  plate  showing  the  hemolysis, 
could be seen  to  occur in the  center of  the hemolytic zone.  Since,  in suitable 
conditions,  new hemolytic lines  can form through preexisting  hemolytic lines, 
it would seem that  the stainable  line is not a  diffusion barrier,  and represents 
not lattice formation between Activated R  and I  but the binding of the product 
of interaction  to the gel (see reference 2). 
FIG. 8. The "stainable  line"  between indicator and Activated  R. The wells contain func- 
tionally purified Activated  Reactor  (R), purified Indicator (I) and normal human serum (S). 
The left half picture is of the unstained plate  after overnight incubation;  the right half pic- 
ture is of the same plate after washing, drying, and staining. 
Characterization  of Indicator as a Complement Component.-- 
(a)  The effect of anti-indicator IgG on complement activity  of serum reagents: 
Anti-I IgG was found specifically to deplete  human EDTA-C of its  ability to 
lyse EAC142  (g.pig)  or  EAC1423  (Hu)  (Table  I).  Human  EDTA  serum  so 
treated  failed  to make  EAC  1 ~  7  cells  with  EAC142.  Similarly,  anlmonia- 
treated  human  serum,  after  precipitation  at  optimal  proportions  with  anti-I 
IgG,  would,  when  tested  on  EAC14Hu,  give rise  to EAC142  and  EAC1423, 
but not to the heat stable EAC 1 --, 7. Finally, activated R  preparations which 
depleted I  from EDTA-C at the same time removed its ability to lyse EAC142 
and to form EAC 1 --~ 7 from them. 
These results suggest that indicator must be either C5, C6, or C7. 
(b)  Specific  tests for  complement  component  activity:  Tests  for  presence  of 
specific complement components in purified I  preparations  were undertaken  as R.  A.  THOMPSON  AND  P.  J.  LACH.I~ANN  639 
described  in  the  methods  section.  The I  preparation  could  be shown  not  to 
contain C1,  C1  inhibitor,  C4, C2,  C3,  C6, or C9 activity. Purified fractions of 
human C1  and C3 contained negligible amounts of I  activity. Purified I  gave 
no precipitation lines with anti-C3,  anti-C4,  anti-CS,  and anti-C6.  The sera of 
mice with a hereditary deficiency of C5 (15)  and of rabbits with a deficiency of 
C6  were both shown  to contain  I. The purified  C8  preparation provided by 
Dr. H. J. Mttller-Eberhard had no I  activity, nor did it react with the anti I 
antiserum,  while  the  anti  C8  antiserum failed to react with  the functionally 
purified I  preparations. I, therefore, must be C7. 
TABLE  I 
Effect  of DEAE-IgG from Rabbit  Anti-Human Indicator  Antiserum on Ability of EDTA-C to 
Lyse EA C1423Hu* 
Reagent added to Human EDTA-C  Hemolysis with EAC1423Hu 
% 
Saline (control)  61 
IgG from anti-I  (0.5 mg) antiserum  9 
IgG from anti-IgG (2 rag) antiserum  67 
* 5  X  l0  s EA incubated 3 rain at 32°C with zymosan-absorbed human serum diluted 1 : 10 
in Veronal-buffered saline (VBS). 
DISCUSSION 
The evidence that  the indicator  factor  is  a  late-acting  complement  com- 
ponent is strong. 
Anti-indicator IgG was able to remove late-acting complement component 
activity from both EDTA-C and ammonia treated C, and such treated reagents 
were  able  to  form  EAC1423  with  EAC142  and  EAC14,  respectively,  but 
were unable to form EAC 1 ~  7. The depleted factor must therefore be either 
C5,  C6, or C7.  Since indicator is present in C5-deficient mouse serum and C6- 
deficient rabbit serum, it must be C7. Purified indicator has been shown by a 
combination  of hemolytic  and  immunochemical tests  to  contain  neither  the 
early complement components,  nor C3,  C5,  C6,  C8,  or  C9.  This confirms its 
identification as C7. 
The fractionation and physicochemical data obtained for indicator are com- 
patible with that previously reported for C7  (16),  although it is more readily 
separated from C5  and  C6  on DEAE-cellulose than earlier reports have sug- 
gested. 
A  monospecific antiserum to indicator has been made and this has allowed 
C7  to  be recognized  after immunoelectrophoresis. 
C7 can readily be quantitated as indicator, using a hemolytic radial diffusion 640  REACTIVE  LYSIS.  I 
test.  This  represents  a  considerable advantage,  since conventional hemolytic 
testing  for  C7  is  difficult and  requires  purified preparations  of  a  number  of 
complement components. 
SUMMARY 
This  paper  describes  the  characteristics  of  the  indicator  factor  (I)  which 
takes  part  in  reactive  hemolysis  and  its  identification  as  the  seventh  com- 
ponent of complement. 
I  was shown  to be a  beta globulin with a  sediment coefficient of 5.7S and a 
molecular weight of about 140,000. 
Experiments  on  the  depletion of I  activity with  anti-I  antiserum  or  with 
activated R  euglobulin showed that I  was a late acting complement component 
necessary for the lysis of cells after the EAC142 stage. Complement component 
analysis  of  purified  I  fractions  excluded  all  known  components  except  C7. 
The  physicochemical characteristics of I  are compatible with  published data 
on C7.  The method of quantitation described represents a  convenient method 
of testing for C7. 
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